Ownership and insider activity for Stevanato Group S.p.A. (STVN): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation.
Price
| Price | $20.24 (closing price, October 29, 2026) |
| Market Cap | $5.5B |
| Exchange | NYSE |
| Country | IT |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-28 | Stocchi Mauro | S-Sale | 13,649 | $293K |
| 2026-08-07 | Santel Luciano | S-Sale | 2,023 | $41K |
| 2026-08-07 | Dal Lago Marco | S-Sale | 4,209 | $85K |
| 2026-08-07 | Magistretti Elisabetta | S-Sale | 2,045 | $41K |
| 2026-06-12 | Balachandran Madhavan | A-Award | 4,975 | |
| 2026-06-15 | Balachandran Madhavan | S-Sale | 1,493 | $26K |
| 2026-06-12 | Dal Lago Marco | M-Exempt | 7,997 | |
| 2026-06-12 | Dal Lago Marco | A-Award | 2,356 | |
| 2026-06-12 | Dal Lago Marco | M-Exempt | 2,303 | |
| 2026-06-12 | Dal Lago Marco | M-Exempt | 2,924 |
Balance Sheet (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 74.5M EUR | 85.4M EUR | 115.6M EUR | 411.0M EUR | 228.7M EUR | 69.6M EUR | 98.3M EUR | 130.5M EUR |
| Short-term Investments | 40.1M EUR | 40.9M EUR | 41.5M EUR | 27.2M EUR | 27.9M EUR | 749,000 EUR | 0 | 2.2M EUR |
| Receivables | 181.0M EUR | 160.6M EUR | 167.2M EUR | 278.4M EUR | 369.5M EUR | 522.5M EUR | 529.9M EUR | 542.2M EUR |
| Inventory | 98.6M EUR | 131.9M EUR | 139.4M EUR | 148.9M EUR | 213.3M EUR | 255.3M EUR | 245.2M EUR | 268.1M EUR |
| Total Current Assets | 394.9M EUR | 449.6M EUR | 492.8M EUR | 866.0M EUR | 845.8M EUR | 861.9M EUR | 880.1M EUR | 934.4M EUR |
| Property, Plant & Equipment | 266.4M EUR | 306.9M EUR | 339.0M EUR | 415.4M EUR | 660.7M EUR | 1.05B EUR | 1.26B EUR | 1.40B EUR |
| Goodwill | 47.2M EUR | 47.2M EUR | 47.2M EUR | 47.2M EUR | 47.2M EUR | 50.0M EUR | 50.0M EUR | 50.0M EUR |
| Intangible Assets | 34.5M EUR | 34.8M EUR | 33.9M EUR | 31.9M EUR | 32.2M EUR | 31.0M EUR | 33.6M EUR | 36.9M EUR |
| Total Assets | 781.6M EUR | 882.2M EUR | 968.0M EUR | 1.42B EUR | 1.66B EUR | 2.07B EUR | 2.33B EUR | 2.54B EUR |
| Accounts Payable | 91.8M EUR | 95.1M EUR | 118.7M EUR | 164.8M EUR | 239.2M EUR | 277.8M EUR | 231.0M EUR | 263.2M EUR |
| Short-term Debt | 51.3M EUR | 65.3M EUR | 63.5M EUR | 37.2M EUR | 64.6M EUR | 135.6M EUR | 106.8M EUR | 121.7M EUR |
| Total Current Liabilities | 243.9M EUR | 262.9M EUR | 316.2M EUR | 338.6M EUR | 462.5M EUR | 574.4M EUR | 477.5M EUR | 535.6M EUR |
| Long-term Debt | 245.2M EUR | 290.9M EUR | 273.9M EUR | 184.0M EUR | 133.8M EUR | 242.0M EUR | 305.2M EUR | 337.6M EUR |
| Total Liabilities | 550.2M EUR | 616.7M EUR | 657.8M EUR | 577.2M EUR | 663.8M EUR | 938.9M EUR | 924.4M EUR | 1.06B EUR |
| Retained Earnings | 0 | 0 | 0 | 0 | 623.4M EUR | 757.9M EUR | 863.4M EUR | 876.4M EUR |
| Total Equity | 231.6M EUR | 265.5M EUR | 310.5M EUR | 842.1M EUR | 996.1M EUR | 1.13B EUR | 1.40B EUR | 1.49B EUR |
| Total Debt | 317.1M EUR | 375.7M EUR | 363.0M EUR | 244.3M EUR | 218.4M EUR | 396.6M EUR | 429.0M EUR | 470.7M EUR |
| Net Debt | 202.4M EUR | 249.4M EUR | 205.9M EUR | -193.9M EUR | -38.3M EUR | 326.2M EUR | 330.7M EUR | 338.0M EUR |
| Working Capital | 151.0M EUR | 186.6M EUR | 176.6M EUR | 527.3M EUR | 383.3M EUR | 287.5M EUR | 402.6M EUR | 398.8M EUR |
Financial Health
| Debt / Equity | 0.29 |
| Current Ratio | 1.61 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 4.01 |
Profitability
| Return on Equity | 8.94% |
| Return on Invested Capital | 6.36% |
| Return on Assets | 5.13% |
| Gross Margin | 29.16% |
| Operating Margin | 16.08% |
| Net Margin | 10.99% |
Related companies: AXSM · BTSG · MMSI · ATR · BLCO · AVTR
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of STVN: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks